USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
It is the first autotaxin inhibitor to be investigated in cancer patients
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Women emerge as the cornerstone of this monumental undertaking
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
These approvals mark significant progress for Venus Remedies in expanding its market presence
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
Subscribe To Our Newsletter & Stay Updated